Haiti Program: Eliminating Lymphatic Filariasis by 2020
Founded in 1993, the University of Notre Dame Haiti Program seeks to achieve the historic goal of eliminating Lymphatic Filariasis (LF) in Haiti by 2020.
LF, a debilitating mosquito-borne disease that affects over 2 million Haitians, is the second leading cause of long-term disfigurement and disability worldwide. It can be eliminated in Haiti through mass drug administration and the distribution of salt co-fortified with iodine and medication. These two treatments will prevent new cases of LF from occurring, while the salt has the added benefit of also combatting Iodine Deficiency Disorder, which is prevalent in Haiti.
The Program also works to alleviate the suffering of those already afflicted with LF. The Haiti Program is partnering with the Haitian Ministry of Health, corporations, non-governmental organizations, and private funders to forever eliminate LF. This innovative work also provides an exportable model for LF elimination in other countries, while fulfilling the University's mission of doing "science in the service of humanity."